Karyopharm Therapeutics Inc. (KPTI) NASDAQ
9.23
-0.59(-6.01%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
9.23
-0.59(-6.01%)
Currency In USD
| Market Cap | 80.48M |
| Enterprise Value | 253.55M |
| P/E Ratio | -1.04 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 1.38 |
| Price/Book Ratio | -0.76 |
| Enterprise/Revenue | 2.31 |
| Enterprise/EBITDA | -2.12 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -1.29 |
| Operating Margin | -0.56 |
| Return On Assets | -1.48 |
| Return On Equity | 0.73 |
| Revenue | 146.07M |
| Revenue/Share | 6.86 |
| Gross Profit | 140.12M |
| EBITDA | -149.85M |
| Net Income | -196.04M |
| Diluted EPS | -17.93 |
| Total Cash | 90.85M |
| Total Cash/Share | 4.13 |
| Total Debt | 230.87M |
| Total Debt/Equity | -0.87 |
| Current Ratio | 1.08 |
| Book Value Per Share | -12.07 |
| 52-Week Change | 117.18 |
| 52-Week High | 10.99 |
| 52-Week Low | 3.65 |
| Moving Average 50 Days | 8.01 |
| Moving Average 200 Days | 7.13 |
| Average Volume | 898,530 |
| Shares Outstanding | 22.66M |
| % Held by Institutions | 167.64 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | February 26, 2025 |